# 89Zr-AMG211 PET Imaging Study

> **NCT02760199** · PHASE1 · COMPLETED · sponsor: **University Medical Center Groningen** · enrollment: 9 (actual)

## Conditions studied

- Advanced Gastrointestinal Cancer

## Interventions

- **DRUG:** 89Zr-AMG211
- **DEVICE:** 89-ZrAMG211 PET

## Key facts

- **NCT ID:** NCT02760199
- **Lead sponsor:** University Medical Center Groningen
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-08
- **Primary completion:** 2017-05-03
- **Final completion:** 2017-05-03
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2024-05-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02760199

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02760199, "89Zr-AMG211 PET Imaging Study". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02760199. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*